Summary – Sales in Oregon’s dispensaries reached $38.7 million in Febraury, a 17 percent increase from the previous Febraury. Compared to January 2018, Adult use and Medical sales combined experienced a seasonal decline of one percent. Sales to adults 21 and over grew 24 percent in February compared to the previous year, while sales to medical patients declined 10 percent.
The sales of flower/bud generated $17.4 million in revenue in Febraury, a nine percent decline from the previous Febraury. The decline in flower sales was driven by lower retail prices. On average, a gram of flower in February 2018 sold for 27 percent less than the previous year. The lower prices helped boost demand as flower sales in fact grew 24 percent by volume from the previous year.
Concentrate sales in February increased 53 percent from the previous year, reaching $10.7 million.Compared to January, concentrate sales grew four percent. Consistent growth in concentrates has lead to increasing share of revenues. In February, 28 percent of revenues from Oregon dispensaries were from concentrates.
With $5.8 million in sales in Febraury, sales of edibles continues to increase in popularity, growing 78 percent from the previous year. Candy, beverages, and tinctures all enjoyed robust triple-digit growth from the previous year.
February sales volume and change from previous month and previous year:
|Category||February Sales||Growth from January 2018||Growth from Ferbruary 2017|
|• Live Resin:||$336K||-4%||78%|
|• Infused Foods:||$245K||-6%||-17%|